KRAS and adenocarcinoma: Importantly, in intestinal and pancreatic mouse models, some TCs are exceptionally long-lived and, when harboring Apc or Kras mutations, are able to give rise to aggressive adenocarcinomas in the presence of inflammatory insult [11,13].